Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

The COMPASS Consortium, The INVENT Consortium, The Dutch Parelsnoer Initiative (PSI) Cerebrovascular Disease Study Group, The Estonian Biobank, The PRECISE4Q Consortium, The FinnGen Consortium, The NINDS Stroke Genetics Network (SiGN), The MEGASTROKE Consortium, The SIREN Consortium, The China Kadoorie Biobank Collaborative Group, The VA Million Veteran Program, The International Stroke Genetics Consortium (ISGC), The Biobank Japan, The CHARGE Consortium, The GIGASTROKE Consortium, Regeneron Genetics Center, The ODYSSEY Study, HUNT All-In Stroke, The SICFAIL Study, The Generacion StudyThe Copenhagen City Heart Study, The SMART Study, Clinical Research Collaboration for Stroke in Korea (CRCS-K) and Korea Biobank Array (KBA) Project, Helsinki Stroke Project, Follow-up Studies, EPIC-CVD

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In the version of this article initially published, the name of the PRECISE4Q Consortium was misspelled as “PRECISEQ” and has now been amended in the HTML and PDF versions of the article. Further, data in the first column of Supplementary Table 55 were mistakenly shifted and have been corrected in the file accompanying the HTML version of the article.

Original languageAmerican English
Pages (from-to)E7
JournalNature
Volume612
Issue number7938
DOIs
StatePublished - 1 Dec 2022

Bibliographical note

Publisher Copyright:
© The Author(s) 2022.

Fingerprint

Dive into the research topics of 'Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)'. Together they form a unique fingerprint.

Cite this